Home Alzheimer’s Disease Phase I/II Trial To Evaluate Dual HER2 Combination Therapy in HR+, HER2+...

Phase I/II Trial To Evaluate Dual HER2 Combination Therapy in HR+, HER2+ Breast Cancer

A phase I/II clinical trial presented at the American Association for Cancer Research (AACR) Annual Virtual Meeting 2020, held April 27-28, 2020, will examine the safety and efficacy of dual HER2 therapy in combination with palbociclib (Ibrance) and anastrozole (Arimidex).1

“Treatment with chemotherapy remains the standard of care in those with newly diagnosed metastatic, triple-positive breast cancer,” Krystal P. Cascetta, MD, assistant professor of Medicine, Hematology, and Medical Oncology at the Tisch Cancer Institute at Mount Sinai, said in a poster presentation of the trial at AACR.2

The multicenter trial will consist of 2 phases, with phase I determining the maximum tolerated dose (MTD) of palbociclib and phase II determining the clinical benefit rate (CBR) of treatment with anastrozole, palbociclib, trastuzumab (Herceptin), and pertuzumab (Perjeta). The clinical benefit…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Reflections on Living With an Incurable Illness : braincancer

(I’ve checked with the moderators to make sure this is appropriate and a good fit for this subreddit. I'm a very private person, and...

This Foramen Magnum Meningioma almost killed me 18 years ago.

submitted by /u/dkrem Continue Reading to the Source

Patients, Family & Friends, and Healthcare professionals : braincancer

I am currently a PhD student based at the Marie Curie Palliative Care Research Centre at Cardiff University. My PhD is focussed on developing...

32 year old singer Tom Parker of The Wanted diagnosed with stage 4 glioblastoma

submitted by /u/Jexlan Continue Reading to the Source

Recent Comments